Company intelligence / Profile preview

Eurogenetica

Likely United Kingdom or Greeceeurogenetica.com ↗

Ownership: Private
Development stage: Commercial

Overview

Eurogenetica provides scientific expertise and operational support for developing and delivering personalized health care genetic tests. The company grew out of the EU-funded EUROGENE project, which included a proof-of-principle clinical trial in Germany, Italy, and Spain. Its main offering includes both the science behind test selection/reporting as well as integration with IT systems like the Rules Toolset. No recent clinical trial results are published.

Therapeutic areas: Other
Modalities: Genetic testSoftware-enabled personalized reporting system
Industry: Molecular Diagnostics

Partnerships

Collaborated on EU-funded EUROGENE project with academic/industry partners across Europe

Beyond the preview

Go deeper on Eurogenetica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eurogenetica.

Explore the full profile